Lohmueller J - Search Results

1

Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumors.

Lontos K, Wang Y, Joshi SK, Frisch AT, Watson MJ, Kumar A, Menk AV, Wang Y, Cumberland R, Lohmueller J, Carrizosa E, Boyerinas B, Delgoffe GM. Lontos K, et al. Among authors: lohmueller j. J Immunother Cancer. 2023 Mar;11(3):e006522. doi: 10.1136/jitc-2022-006522. J Immunother Cancer. 2023. PMID: 36914208 Free PMC article.

2

Engineering synthetic TAL effectors with orthogonal target sites.

Garg A, Lohmueller JJ, Silver PA, Armel TZ. Garg A, et al. Among authors: lohmueller jj. Nucleic Acids Res. 2012 Aug;40(15):7584-95. doi: 10.1093/nar/gks404. Epub 2012 May 11. Nucleic Acids Res. 2012. PMID: 22581776 Free PMC article.

3

A tunable zinc finger-based framework for Boolean logic computation in mammalian cells.

Lohmueller JJ, Armel TZ, Silver PA. Lohmueller JJ, et al. Nucleic Acids Res. 2012 Jun;40(11):5180-7. doi: 10.1093/nar/gks142. Epub 2012 Feb 9. Nucleic Acids Res. 2012. PMID: 22323524 Free PMC article.

4

Rationally designed logic integration of regulatory signals in mammalian cells.

Leisner M, Bleris L, Lohmueller J, Xie Z, Benenson Y. Leisner M, et al. Among authors: lohmueller j. Nat Nanotechnol. 2010 Sep;5(9):666-70. doi: 10.1038/nnano.2010.135. Epub 2010 Jul 11. Nat Nanotechnol. 2010. PMID: 20622866 Free PMC article.

5

Modeling recent human evolution in mice by expression of a selected EDAR variant.

Kamberov YG, Wang S, Tan J, Gerbault P, Wark A, Tan L, Yang Y, Li S, Tang K, Chen H, Powell A, Itan Y, Fuller D, Lohmueller J, Mao J, Schachar A, Paymer M, Hostetter E, Byrne E, Burnett M, McMahon AP, Thomas MG, Lieberman DE, Jin L, Tabin CJ, Morgan BA, Sabeti PC. Kamberov YG, et al. Among authors: lohmueller j. Cell. 2013 Feb 14;152(4):691-702. doi: 10.1016/j.cell.2013.01.016. Cell. 2013. PMID: 23415220 Free PMC article.

6

Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting.

Ruffo E, Butchy AA, Tivon Y, So V, Kvorjak M, Parikh A, Adams EL, Miskov-Zivanov N, Finn OJ, Deiters A, Lohmueller J. Ruffo E, et al. Among authors: lohmueller j. Nat Commun. 2023 May 9;14(1):2463. doi: 10.1038/s41467-023-37863-5. Nat Commun. 2023. PMID: 37160880 Free PMC article.

7

Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines.

Lohmueller J, Finn OJ. Lohmueller J, et al. Pharmacol Ther. 2017 Oct;178:31-47. doi: 10.1016/j.pharmthera.2017.03.008. Epub 2017 Mar 16. Pharmacol Ther. 2017. PMID: 28322974 Free PMC article. Review.

8

Editorial.

Lohmueller J, Cascio S. Lohmueller J, et al. Cell Immunol. 2019 Sep;343:103967. doi: 10.1016/j.cellimm.2019.103967. Epub 2019 Aug 21. Cell Immunol. 2019. PMID: 31447052 No abstract available.

9

Conditional Control of Universal CAR T Cells by Cleavable OFF-Switch Adaptors.

Kvorjak M, Ruffo E, Tivon Y, So V, Parikh A, Deiters A, Lohmueller J. Kvorjak M, et al. Among authors: lohmueller j. ACS Synth Biol. 2023 Oct 20;12(10):2996-3007. doi: 10.1021/acssynbio.3c00320. Epub 2023 Oct 4. ACS Synth Biol. 2023. PMID: 37791909 Free PMC article.

10

mSA2 affinity-enhanced biotin-binding CAR T cells for universal tumor targeting.

Lohmueller JJ, Ham JD, Kvorjak M, Finn OJ. Lohmueller JJ, et al. Oncoimmunology. 2017 Oct 26;7(1):e1368604. doi: 10.1080/2162402X.2017.1368604. eCollection 2017. Oncoimmunology. 2017. PMID: 29296519 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page